Home>ABOUT US>History
- 2011 Completion of cGMP plant dedicated for carbapenem and general APIs
- 2010 Expanded business to formulations (prescription, OTC, bio-based products)
Sales revenue reaches 100 Million USD - 2009 Completion of Sichuan factory in China
Company name changed from Daewoong Chemical Co., Ltd. to Daewoong Bio Inc. - 2007 Acquired Roche Korea plant at Ansung site
Obtained CEP for Cefuroxime Axetil - 2006 Renewal of Factory 2 in Hyangnam
- 2005 Acquired Lilly Korea plant at Hyangnam site
- 2003 Obtained ISO 14001 Certificate for environmental management
- 1999 Listed on KOSDAQ
- 1998 Obtained BGMP through FDA
- 1997 Registered as a member of the Korean Specialty Chemical Industry Association (KSCIA)
- 1994 DMF approval by US FDA for Amoxicillin
- 1993 Construction of Factory 2 in Hyangnam
Merged with Samwoong Chemical Co.,Ltd - 1991 Research Institute established
- 1983Daewoong Chemical Co., Ltd. established specializing in API manufacturing
API manufacturing business initiated at Factory 1 in Hyangnam
- 2011 Received award for“50 Million Dollar Exporter”
- 2005 Coenzyme Q10 was nominated for“Korean World-class Product Award 2005”by the
Minister of Commerce, Industry, and Energy - 2000 Nominated“Superior Company in High Technology Competitiveness”
- 1999 Received award from the President of Korea on the 36th Trade Day
Received award for“10 Million Dollar Exporter” - 1997 Received“Competent Manufacturer”approval by Gyeonggi Province Governor
- 1990 Received award for“5 Million Dollar Exporter”
- 1986 Received award for“1 Million Dollar Exporter”
